Infusional vinorelbine in relapsed or refractory lymphomas

Leukemia and Lymphoma

Volumn 39, Issue 3-4, 2000, Pages 291-299

  Sarris, A H ^a   Psyrri, A ^a   Hagemeister, F ^a   Romaguera, J ^a   McLaughlin, P ^a   Rodriguez, M A ^a   Bachier, C ^a   Younes, A ^a   Mesina, O ^a   Oholendt, M ^a   Medeiros, L J ^a   Samuels, B ^a   Adams, L M ^a   Cabanillas, F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Infusional vinorelbine; Lymphomas; Refractory; Relapsed

Indexed keywords

BETA 2 MICROGLOBULIN; LACTATE DEHYDROGENASE; NAVELBINE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; BOLUS INJECTION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEVER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUROTOXICITY; NEUTROPENIA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0034488064     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009065828     Document Type: Article

References (28)

1. Clinical studies with vincristine
2. The binding of vincristine, vinblastine and colchicine to tubulin
3. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class
4. The binding of vinblastine to tubulin and to particulate fractions of mammalian brain
5. A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy
6. Twenty years of MOPP therapy for Hodgkin's disease
7. Treatment of advanced-stage Hodgkin's disease: Alternating noncrossresistant MOPP/CABS is not superior to MOPP
8. Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas
9. Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
10. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules
11. A phase II study of Navelbine (Vinorelbine) in the treatment of non-small cell lung cancer
12. Experimental antitumor Activity of Navelbine
13. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma
14. A three-arm trial of Vinorelbine (Navelbine) plus cisplatin. Vindesine plus Cisplatin, and Single-Agent Vinorelbine in the treatment of non-small cell lung cancer: An expanded analysis
15. Phase II study of Vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease
16. Improvements in clinical benefit with Vinorelbine in the treatment of hormone-refractory prostate cancer
17. Phase II study of Vinorelbine (Navelbine) in Previously Treated Hodgkin's Disease and Non-hodgkin's Lymphomas
18. Clinical study of Navelbine activity in Hodgkin's disease. Phase II study
19. Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease
20. Activity of single agent Vinorelbine in pretreated Non-Hodgkin's lymphoma
21. Vinorelbine in the treatment of lymphoma
22. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer
23. Non-parametric estimation from incomplete observations
24. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
25. ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study
26. Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP
27. A summary of vinorelbine (Navelbine) safety data from North American clinical trials
28. Vinblastine sulfate vs cyclophosphamide in the therapy of lymphoma